In This Article:
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) instance, it's good news for shareholders.
Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.
Check out our latest analysis for ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Insider Transactions Over The Last Year
Over the last year, we can see that the biggest insider purchase was by insider Dirk Van Hyfte for US$106k worth of shares, at about US$0.43 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$0.36). Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.
While ImmunoPrecise Antibodies insiders bought shares during the last year, they didn't sell. They paid about US$0.47 on average. I'd consider this a positive as it suggests insiders see value at around the current price. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!
ImmunoPrecise Antibodies is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.
Insiders At ImmunoPrecise Antibodies Have Bought Stock Recently
Over the last quarter, ImmunoPrecise Antibodies insiders have spent a meaningful amount on shares. Not only was there no selling that we can see, but they collectively bought US$307k worth of shares. This is a positive in our book as it implies some confidence.
Insider Ownership Of ImmunoPrecise Antibodies
For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Our data indicates that ImmunoPrecise Antibodies insiders own about US$1.7m worth of shares (which is 9.2% of the company). We do generally prefer see higher levels of insider ownership.
So What Do The ImmunoPrecise Antibodies Insider Transactions Indicate?
It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. While the overall levels of insider ownership are below what we'd like to see, the history of transactions imply that ImmunoPrecise Antibodies insiders are reasonably well aligned, and optimistic for the future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing ImmunoPrecise Antibodies. Case in point: We've spotted 3 warning signs for ImmunoPrecise Antibodies you should be aware of, and 1 of these is concerning.